title: [Taxol in advanced cervical cancer].
authors.affiliation: Division of Obstetrics and Gynecology, Tokuyama Central Hospital.
authors.forename: Kei
authors.initials: K
authors.lastname: Hirabayashi
authors.forename: Jun
authors.initials: J
authors.lastname: Ito
authors.forename: Masayuki
authors.initials: M
authors.lastname: Kobayashi
authors.forename: Fumitaka
authors.initials: F
authors.lastname: Numa
authors.forename: Takehisa
authors.initials: T
authors.lastname: Ito
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009367:Neoplasm Staging; D017239:Paclitaxel / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant; D014407:Tumor Cells, Cultured; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel; D002945:Cisplatin; D005472:Fluorouracil